News

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...